LB Pharmaceuticals Inc Common Stock (LBRX) financials · $803.4M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
LB Pharmaceuticals Inc Common Stock (LBRX) $803.4M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Net Income | -$25.2M | -$63.1M |
| EPS (Diluted) | -$3.13 | -$176.15 |
| Line | FY2025 |
|---|---|
| Total Assets | $312.9M |
| Current Assets | $308.4M |
| Cash & Equivalents | $250.2M |
| PP&E | $1.58M |
| Total Liabilities | $11.6M |
| Current Liabilities | $7.44M |
| Shareholders' Equity | $301.3M |
| Retained Earnings | -$129.5M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$35.2M | -$53.1M |
| CapEx | $52.0K | $769.0K |
| Investing Cash Flow | -$39.9M | $23.2M |
| Financing Cash Flow | $302.6M | $38.3M |
| Net Change in Cash | $227.5M | $8.50M |
| Free Cash Flow | -$35.3M | -$53.8M |
FAQ
What is LBRX P/E and revenue?
LB Pharmaceuticals Inc Common Stock (LBRX) $803.4M cap.
What is LBRX revenue?
LBRX income-statement cache has no revenue figure yet.
Is LBRX profitable?
LB Pharmaceuticals Inc Common Stock last cached net income is -$25.2M (FY2025).
What are LBRX total assets?
LB Pharmaceuticals Inc Common Stock last cached total assets are $312.9M (FY2025).
What is LBRX free cash flow?
LB Pharmaceuticals Inc Common Stock last cached free cash flow is -$35.3M (FY2025).
Not investment advice. Cached statements, not a live tape.